Pressure-driven foam cell formation revealed as key driver of arterial disease, paving the way for new therapies
JANUARY 5, 2024byQueen Mary, University of LondonChronic Yoda1 treatment supports transition to a foam cell phenotype. A-B) Wound scratch assay shows reduced migration of Yoda1 treated A7r5 cell
Updated on: March 25,2024
5

Pressure-driven foam cell formation revealed as key driver of arterial disease, paving the way for new therapies
JANUARY 5, 2024byQueen Mary, University of LondonChronic Yoda1 treatment supports transition to a foam cell phenotype. A-B) Wound scratch assay shows reduced migration of Yoda1 treated A7r5 cell
Updated on:March 25,2024
5
